Abeona rises on FDA approval for skin disorder therapy

ReutersApr 29, 2025 10:16 AM

Shares of drugmaker Abeona Therapeutics ABEO.O up 12.7% at $6.03 premarket

ABEO says the U.S. FDA has approved its gene therapy for a rare skin disorder

The gene therapy, called Zevaskyn, is approved to treat adult and pediatric patients with recessive dystrophic epidermolysis bullosa

The current standard-of-care treatment is daily wound care and protective bandaging

Company says the treatment is expected to be available in Q3 2025

As of last close, ABEO shares down 4% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Why SanDisk Stock Could Soar to $4,000?

If SanDisk continues along its path and actually achieves the consensus estimate of $168 in earnings per share in one year, a P/E multiple of 22 — which is a rather conservative estimate of the S&P 500 average — would imply a stock price of close to $4,000.

Micron Surges 38% in a Week, Market Cap Breaks 840 Billion, Can This AI Memory Leader Continue the Rally?

TradingKey - Driven by the explosion in AI storage demand, Micron Technology (MU) shares have surged for five consecutive trading sessions since May 1, with a cumulative weekly gain of approximately 38%. The stock closed up over 15% at $746.81 this Friday, hitting a record high. Its market capitalization surpassed $840 billion, with daily turnover reaching $46.36 billion, ranking first in the U.S. stock market.

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

TradingKey — Intel (INTC) shares surged on Friday following reports of a preliminary cooperation agreement with Apple (AAPL). The stock’s intraday gain briefly exceeded 13% before closing up 13.96%, with its market capitalization jumping to $627.8 billion.

Trump’s Shifting Stance Deadlocks US-Iran Talks, Citi Maintains $120 Brent Target

TradingKey - On May 8 (ET), Citi stated that oil prices could rise further if US-Iran negotiations remain deadlocked, maintaining its forecast that Brent crude will reach $120 over the next three months.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools